Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000539591 | SCV000623811 | likely benign | Hypertrophic cardiomyopathy | 2024-10-31 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001805146 | SCV002053620 | likely benign | Cardiomyopathy | 2021-02-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002367763 | SCV002666123 | likely benign | Cardiovascular phenotype | 2020-10-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV000539591 | SCV004815460 | likely benign | Hypertrophic cardiomyopathy | 2024-02-05 | criteria provided, single submitter | clinical testing |